TRPM2 and neurodegenerative disease: These studies all indicate that the TRPM2 channel is a potential drug intervention target for the treatment of a variety of neurodegenerative diseases (Wang et al., 2016; Yamamoto and Shimizu, 2016; Belrose and Jackson, 2018; Sita et al., 2018).